When a new vaccine is approved, the virus can be wiped out
An outbreak of S. pneumoniae infections in Europe this summer has exposed a new vulnerability of the world’s vaccine, which is designed to eradicate infections caused by S. meningitis but also to protect people from disease that has been largely eradicated by other vaccines.
The European outbreak is the most serious since the first of several S. disease outbreaks in Europe in 2009.
It has infected more than 3,000 people, including some of the country’s top public health officials, including the chief of the national police.
Some of the most prominent cases of SMI were traced to a small family farm in the county of Morlond, on the southern German border with France.
The farm was not the only one to be hit, but it is now the focus of a public health effort to find and isolate the source of the outbreak.
As the story of the farm has unfolded, the government has said it has uncovered a link between the farm and the outbreak in Morlonde.
But the farm’s owner says the farm was never connected to the outbreak there.
It is not clear how the farm is connected to all of the S. infections that have infected people in Europe.
It was also not clear what role the farm played in the outbreaks in Germany.
Some people in Germany and the Netherlands suspect the farm, which had been producing potatoes and other agricultural products for more than two decades, was a staging ground for the outbreak on the other side of the border.
As part of the effort to identify the farm as the source, the country has launched a nationwide vaccination campaign, deploying an unprecedented amount of resources and personnel to help prevent further infections.
But researchers say they do not know for sure that the farm itself was responsible for spreading the SMI outbreak, which could pose a new risk for the rest of Europe.
The Morlons farm, located in a rural area near Morlont, was the main site of the disease outbreak.
It grew wheat, barley, oats, barley and barley.
The local farmers also grew wheat.
The owners say that in the summer of 2015, when they received the first inoculation of a vaccine against S. aureus, they noticed that some of their animals seemed sick.
The animals were suffering from a disease they didn’t know existed.
The farmers thought it was related to the strain of S-manuelis that had recently been introduced in Germany, but the virus did not appear to have any effect on their animals.
So they decided to start using the vaccine in spring 2016.
“We thought that it was going to be a good thing for us, because it would stop us from having more animals die,” said Michael Bärtgen, the farm owner.
Bättgen says he thought that the S-aureus strain would be harmless and that the herd would grow back.
But when they started to see the virus in the herd, Bätgen and other farmers began to suspect the herd had contracted it from the farm.
“There were some cases where we thought they were having fun,” Bätkertgen said.
The herd grew in numbers, he said.
They started to vaccinate more animals.
Then, the disease started to spread more rapidly in some areas, spreading from one farm to another.
The first outbreaks of S MI occurred in 2014 and 2015.
The second outbreak occurred in March and April of this year.
There were three reported cases in the Netherlands and Belgium.
Researchers say the new S. cases are particularly worrisome because of the way the disease spreads.
The virus is passed through a person’s mouth, and it spreads by direct contact with infected saliva, which can contain proteins that are normally destroyed in the mouth.
SMI can also spread through the blood stream, which includes the lymphatic system and brain.
“It is very hard to determine the cause of S MINE,” said Professor Jean-Pierre van der Meer, an infectious disease expert at the University of Limburg in Belgium.
“So far we have only identified a very small number of cases that were isolated in the laboratory, and we don’t know why the virus was spreading.”
There is no cure for SMI, which usually begins with a fever, cough, and other symptoms.
It usually progresses to a full-blown illness that requires a host to take medication to fight the disease.
About a third of people infected with SMI die from the disease, but most people recover.
A small number, mostly in the developing world, become severely ill, with pneumonia and liver failure, followed by a coma.
It can cause severe nerve damage and death.
A third of S mites can spread to other people, potentially causing infection and death if they are not properly treated.
There are about 1.8 million cases of the virus worldwide.
It affects an estimated 7.2 million people worldwide, according to the World Health Organization. S